Mentor breast implant trial amended
This article was originally published in The Gray Sheet
Executive Summary
FDA approves a protocol change May 2 to the firm's 10-year post-approval study for its Memory Gel silicone-filled breast implants to allow patients to receive the implants even if they do not participate in the study. Access to Memory Gel will continue to be available only through physicians participating in the study (1"The Gray Sheet" Nov. 27, 2006, p. 3). Mentor says it has enrolled close to 4,000 patients in the 40,000-patient study since the implants' conditional approval in November...
You may also be interested in...
Sales Of Silicone Breast Implants To Easily Offset Post-Approval Study Costs
Mentor expects to spend up to $45 mil. over the next 10 years on an extensive post-approval study of its Memory Gel silicone-gel breast implants
Deal Watch: AbbVie Teams With MedinCell On Long-Acting Injectables
Collaboration Edition: Including deals involving Evotec/Variant, Sanofi/IGM/Nurix, ABVC/OncoX and Harmony/Bioprojet, along with tech transfer agreements and deals in brief.
GE HealthCare Launches AI-Powered Voluson Ultrasound For Women’s Health
Voluson Signature 20 and 18 ultrasound provides clinicians with workflow efficiencies in detecting female reproductive health problems, especially those related to pregnancy.